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Sever&l controlled cL&.!f t&s (l-5) .have demonstrated a 
steep, linear relation *~:~een t&z te treatment -aud subse- 
qjtent murtality. In the rcwdy completed Global Ut&&ion 
of Strepiokiaase anil ?iis& Plasmitiogen’ Activator for; Oc- 
cluded Coronary Arteries (bUSTQ trial (6,7), there was a 1% 
reduction in mortality associated IR<?~ each Zour of time saved 
‘in honrs 2 to 6 after synqtom onset,(Fig. 1); In the~overview of 
the large &uqean mntrolled trials of thrombolytic therapy, 
there’was a near-~&ear reduction in tee relative benetit of 
tbrombolytic therapy related to deia:-. The greatest relative 
diEerenee in murtaljty was,, observed in & small number of 
patients +&ted -in: the first, hour after:symptom cnse:! (5). 
ThZrefore, &I iiupbrtant treatment’ modification in thi usual 
delivery of thromboiytic therapy that would ‘result in reduced 
mortality is to reduce the average time to treatment for ali 
jarients by I: tii 2 h over the usiial trtiatment t&s today. 
Treatment ‘within~thc;‘firfirst .hour of symptom o&et w@ no! on&, 
r+duce motiity, but, iri,up to 4U% of ‘patients ,wiI also aburt 
the qxxai&tt infarction proc.c& @even&g irrcver&le my& 
&dial damage &xd dysfunction (8). fn addition, sudden, 
unexpected cardiac death .accounts for over,half of the mar- 
t&y associated’. with. acute :.myo&rdia,l infaicti?n, and :most, 
.leatl$ pccur iu the &it few hours of infti~>n.:Tlqs, i&&i- 
ficatixr df patients with qcute myocardial iufarcticn aru! initi- 
ation of treatment *tlGn the 6rst ihcs:t Qf onset; of svmPtl;ms 
(%e g&en ho&‘) should be B gu+ in ah patie& tith a&a 
.myoc&ti~ infarction who are : potentially eligihl~ for either ‘, .-. .. : 
‘..., “’ ,i) . : 
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thrombolytic therapy or primary coronary angioplasty. Fach if 
the ‘barriers to early treatment and ‘the expe&ed effect tif 
ediertieam~nt~d~sednext.. : ::. 
‘. ‘_ : 
Patht delay. The delay from onset of fiym$m utlry 
initiation to treatmeot can be divided into three components: 
1) the time ie+red by the. patient to recognize the njhue and 
inipor;ance of the problem aqd deter&c the need tb seek 
medica] caq; 2) the transport timi: to the hospital; ‘and 3) tlG 
t@e ffotp hospit$ arriva! to initiatic3’of rape* treatment 
@ig. 2): ‘, ; :’ ‘: ‘, ; ‘. _-, ’ ,’ ‘. 
Tbk mediG time from symptom onset to seeking care is 4 h. 
Thedstriition of delay is skewed by the l&G to 15% of 
patients who arrive extremely late, 12 h qr later after sympt41m 
onset. Tb$ me&an d&y in t!! subset of Patients e#giHe to 
receive tbrombolytic therapy is ‘2 to f h, but stti 49% of 
patients waii 54 h bef@re~seeking @zdi&heip (9). The camzs 
of prdonged patient qdqrs are muttif;lctorial and iltchde the 
$i%knt’s lack of awaryms -of the pr-rice: @f known risk 
‘factors; for heart disease, the tjme-?f day (of sY;nptom,omiet), 
‘perceptious about the severity of sympto@, older a@ and 
j, female &rder (9-15): T&is patient-related coml,tanent of totat 
delay, r+resents two-th&ts tif the:: $4 time :from symptom 
unset to .Wiation of rexxfusion thetipy. To date; @atient 
‘delaju h&ve beeu particn~ resistant to mod’f’icaon through 
media’e~ucation @~13,14,‘,5~20). ., I ‘. 
., A large; i&bqm%y registry of patients with a& ruyo- 
can-lid ix&it&n p&ides some hisight into fk rnw of 
patient delay in relatively unselected Ip8’iextK The Narioual 
I-&e!- ‘of h+3&rdi~ ‘UrIrctiiorg. tide& used in >l,ow, 
45’ j 
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Figure 1. Mortality’ rate v~fsus time to tfiztttnent in the 
GUSTO trial. Mortality increased 19;h .ig the firrct 4 h 
after symptom onset. -@%I from The GUSTO Investi- 
gmtr j7j. ).- 
&zpitaJs in t&United St t’ a es, contains a one-page. assessment 
of the clinica! and treatment data about patients admitted to 
‘the hospital with xute niyocardial infarction (21). The Registry 
underrepresenti srr@ and rural hospitals having sl0I.l beds 
*cl may overrepresent, the ,&set :jf patients with. acute 
infarction who receive ‘thrc &~&tic therapy. Despite the fact 
that fhe ‘&dings in the registry maj not be enti:ely,:epresen- 
tative’ of al! patients with myocardial infarCtion, the large 
,+mmt of data from >17$,oofl patients collected in 7991 to 
.I993 show that the mean @e&an) delay from onset of chest 
pain until treatment with th~utnbolysis was 2 II 50 min (1 h 
34 minj cumpaqd with a delay y-of 6’h 9 ,min (2 h 41 min) in 
iboSe patients not, receiving thrombolytic, drug. treotti.A, 
rspectivefy {21). fitbWgh 2.5yg Of patients tiqd at hOSpA 
in:jttsi over an hour, &another 25% did ,not arrive until 6 h or 
.later a&r chest pain bnset, including 138 who arrived 12 h or 
later when the “window fur pharmacoIogic means for reperfu- 
sionj is closed.” The average delay ~frorn symptom onset ,to 
:arim’ission waialsc longer for women titan men (5.7 :,s. 419 h) 
(9): ., 
P&@J &aztixz 7$&-e have b&n xverd &tempts to use 
the mass media to,p@de he;ljh e@&tion or motivational 
messages to shorten this’ L@atient-reIate# cotipbnent of deiay. 
(10,16~20). Ii&t stuches aimed af evaluating the effectiveness 
tif tiedia,at&np& have either been tnrr 5::1all to measure an 
effect- adequately, too- short in duration to “penetrate” the. 
targcl :udiencc or inadequately controlled such that itrterprr- 
tatiDn of the elfectiveness of the media intervention is nearly 
Lmpossible. The studies of media effectivenes have shown 
varied suc~sss at reducing -patient delay times. UnfortunateIy, 
most of the larger ones that have statistical power to ‘assess 
effectiveness of the #intervention have been, done outside, the 
United St&es in tioutitries where health care systems differ 
considerably from out cwn (16-20). The findings from these 
experiences, therefore, may not be indicative of what might 
occur in the United States. In Giiteborg, Swede& a mass media 
campaign &bed a~cor&inati& &f radio. p&t and billboard 
advertising for; .l year with a, befcire-and-aft& assessment of, 
time tb treatment. During the,iqittial,ph:se of the intense radio 
camptign, there was a marked increase ir the number of 
patients arriving at hospital who had chest pain not related to 
acute coronary syndromes. Although this excess in inappropri- 
ate hospital utilizatibn decreased rapidly after c~aation of the 
radio advertising, the finding highlights the difficulty in ade- 
quately targeting a message to patients with aGute mronary 
ischemiti versus patients with chest pain related to other causeS 
(16). Dueng. the media. intervent@; there was Ino iqease,in 
the propO&oc of patients with’ myoca&l infarction &i&g 
by ambulance; however, the average delay from symptom o?- 
set to &nissjon in those patients with. acute infal-ction was 
Figure 2.. Components of delay in maaagemer,: -bf 
patients with acute myocardiat infarction. Two-third! 
of delay is paiielit related, and 25% is. Ii&pitat, 
related, The times shown represent the ercperienti in, 
the’ ,Myoc&ial 1nfn;ction. Triage and inteyent$n 
(MITI) acute myocardial infarcti&regisuy of 8,WU 
patients in Sea$e. Washingttin. ECGs = electrocar~ 
:‘diogranjs. ,; ., ” ;’ . . : :. .- :. -:: 
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ieduced by &uosx 1 ,h. Also. the portion of patients with ST 
segment elevation xriving within 6 h (a’ group most benefited 
by thrombdysis) increased (from 3f& to 36%).‘.Infaict s+e, as 
measured. by enz& he @vels; was estimated ti, be 40% smaller in 
patients treated af:er the campa’ign, and this effect ,was judged 
to reflect a’reduced time to tre?tment (20). 
.2njr succcss~l education program capatile of reducing the 
Xime from symptom onset until’ hospital arrival for patients or 
that results in an increase .in the use of prehospital services is 
likely both to enhance the Lumber’ of patients eligible for 
reperfusion strategies (thrombolysis and pexutan~ous traas- 
luminal coronary angioplasty) as well as to decrease the 
“number of out-of-hospital sudden-deaths. 
These finding point out the heed for well designed, con- 
tro!led. community media interventions aimed at reducing 
these times. The’available data are discouraging and show that 
modifying patient behavior is difficult. 
Hospital transport. Despite the presence of pziamedic 
services in essentially all Qedium- and large-sized. cities, OI;;Y 
SO% of Fitients with acute myocardiai infarction @I 911 and 
use paramedic-statFd emergency services for hospital trans- 
port. Althoughout-of-hospital deaths are not easily discernible 
‘in patients with acute infarction, it has been estimated that up 
to 20% of patients die at home (22,X+ Patients who transport 
themselves to hmpital come r2.h later than those patients who 
call 911 (8). They are less likel)’ to have severe pain and less 
hem$ynamic czrqtromise and are less likely to receive throm- 
bolytic therapy and have a lower morta&ty rate (8,24). 
Prehospital emergency care providers can play a major rote 
in reducing time to treatment of patients with acute myocardial. 
infarction; however, in only a few cities are there organized 
-‘attempts to improve the initial triage and Management of 
patients with cheSt pain. Most paraniedic systems make no 
at:empt at identifying the subset of patients with acute coro- 
nary symptoms from those with nonzpecihc chest pain. Also, 
.little is d&ie. to’ focius attention ?t $nimizing the time to 
‘coronary rep&fusion. For the past 6 years In Seattle, we have 
llsed a chest pain checkhst~ of &ic@criteria to help identify 
patients eligible for ,reperfusion therapy (25). Without a di- 
rected approach such as this, the prehospital evaluation and 
.&atnient time &ir v&r-y considerably, taking 30 to 60 min, ‘and 
fail to. identify th~mbolysis,‘candidates (26). Prehospital e&- 
tlocardiog;aphy I carr be performed for ‘al) ‘jiatients ;vith chest 
‘pain and. reduce the time for emergene department evalua- 
,t@n and’iime td,tr,eaJmcnt (X-29). ,’ 
: The goal for the’ 199os’~will be to reduce ~;rehes&l t&&tent 
‘+d. t&sport, time for ,a11 $atients and provide. tirehospital 
electrocardiogral$y as routine care. : 
~aspi~-related d&-r$ ?he hospital &mponent of delay is 
ptitentially-&r&oQ@le by ~@hys&iati’and nur&s, andfor most 
~~Gws time to trez@eitt’ cart biz shortened ftim the current 
average of.6fi &I to s36’miti. me factors ir$Iukncing hospital 
treatment tit-& ‘include. that spent by ‘nursing, emerge* 
physieiatr evaluation, consult&ion, lab&tory tesiing and phar- 
macy In patiet+ witi. typical el ectroc&io&aphic [ECG) and 
clhica~fiitdiff aid cx~worbkl risk fidwrs, 30 oiin is’adequate 
i . ,!‘- 
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Figure 3. LJ C%t of delay of thromboiytic treatment on infarct size. 
Numbers above cohmos are number d patients. CO~~~IIS = mean 
YaJues; vertid bars 5 95% mlfidenoe inteds. In the patients treated in 
the first hour, there was a Stqwke (50%) tid nonlinear reduction in the 
size of ttre resulting iIlfarcL a, = cumulata~ isctivity CffIIlpxnw 
alpF+hyc%oxy&tymte dehydrogenax released per liter of pbma during 
%t 24 h after acute my~~~dial i~~farction.’ (From Hermens WT, 
WJicm GM, Nijssen KM. Sirnoons ML. for the ikopean Coopers 
G-tic SW+ Group. E&xt of throm@olytic treatment delay OII myocar- 
dial .k&rct rice.’ Lanwt, 1992,34&?2!V. @printed with permission)’ 
: ,. 
to initiate throlnbolytic therapy. C&e way. to reduce time to 
treatment is to remove the routine requiremeni for personaI 
physician and cardiolcgist bedside consultation before initiai’ 
tion of treat&x& A ptotocol for ideentifying “typical and 
uncompIicice;ed” patients eligible for treatment with thrombol- 
ysis should be developed jointly by cardiologists and emer- 
gency physicians. It’ should empower the Tatter to initiate 
therap)i in. such ~‘typitil~‘, pfient+. Ilie fac++le mach@e m 
be used to &t expert interpretation of questroeble ECGs, and 
“‘,routirx” xxXr5uItation c&u im&diately follow, iristead of : 
precede, the, order to initiate treatment. la this .way; most 
patier& can be treated without the delays inherent with 
cdllSUl’Zdi~Xi. 
Imlportanc~ of Very :&dy Ts-ehkut :j 
., 
I There is considerable evidence that. redu&g the time’ to 
treattreat .of paiie,nls with a&e rity&xdial infarcti9n Can 
markedly attenuate miocard&l’ infar@ Size. OIle of’ the fbst 
reports evaluatirrg the +t.s of time to tr&tmeut and inrct 
size [using enwtatic area tinder the curve assesstient).showed 
‘a n&linear relation& p&em3 treated very ear& (3rJ).ti- 
‘was a SO? 1 ,.r@+ctron In’-& of my-dial infarction \ti the 
subset of patients -tr&xf within, the first .75 ruin’ of, chest @in 
onset laud then a lesser and m&e ,ti$&r effect of treatmerxt 
‘after @at time {Fig. 3)~ 
‘, : .’ 
A sim&5ntii~~g.for patients &at& with@ the first 60 to 
80 min was ,k$d in ‘the: Zytix~dial Infarctiofr ?i-iage r& 
- Infarct size in patients with occluded vessels [TPATl 
$, 2q+- rlmrct size ii control patients [Wwrv, WWIC] &/ 
aa ;’ > 
x + 2,3 R2 = 0.85) 
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Figure 4. Infarct sizekby time to treatment. These 
data ,shtJw a stcefi Iinear reI+on, berwecn, infarct 
size and titie ta treatment as mea&xl by the sirnq 
core l&oratory lusiitg tom~grapliic thallium iii);ocar- 
dial imagmg. ‘pe largest infarct size was in the 
Western VJaSqtrrn !,iitracm-- .2p.+ Stie@h!X 
Trial (WWIC) i(titic to tieatment 4.7 .h), and the 
smallest w+ m tkd Mmial. Infarcticq Triage 
and Intervention (METI) pretiospipal trial (time to, 
treatm&t 1. f’ h). The Western Washington !+ave- 
noes. Streptokinase ‘Trial (WWIV) (coronary care 
unit treatment) and Western Washington Intrave- 
naus I-PA (WWTPA) study (emergency depart-, 
mcnt)-showed intermediate re+lts. APSiM = Bas- 
sand et aI. (33); Bassand = Bassand et al. (34); 
TFAT = Tissue P!asminogen, Activator, Tomnto. 
(From Martin GV, Kennedy JW. Choice cf throm- 
bo@?ic agent. In: Julian D, Braunwald-E, editors. 
Cantemporary Management of Acute Myacardial 
Infarction. Philadelphia: Saunders, lYG4.3-ltE. 
Reprinted tith permission.) 
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Intervention-(MPTI) prehospitat trial (8). There was a marked 
red&on in infarct size (measured in this ,$ase by tomographic 
tIm.lhm imaging) in patients mated within the first 40 to 
-80 min after chest pain’ onset. In fact, 4oF of patients treated 
&thin 70 min of symptom’onset showed no measurable infarct 
on’tbe ihges t&en 30 days after treatment (8). As ‘the’time to 
@earme& has shortened &h moving thrombolytiti therapy 
from intracuro~ adtititratior; in the’catheterization labo- 
ratory b intrtyenuus admhistiation at the door of the emer- 
gency depqmehi, $e resulting infarct size h& also decreased 
marke.&y (Fig 4). The available itudies suggest that myocar- 
did s&&e after tre$ment with thrombofysis is not linear and 
th3t subgtautially greater sa]vqe is possiile in the first hour 
cotqmed .with that,‘~ossible- wit! treatment ‘lat$r. Although 
time is nut the solis 1detqminarit of infarct si+~, tihich is al& 
idwnced by the leqgtb’ id a&&& dist+b&on of the 
.infqrct-+&xi artery, the presence or absence of collate+al 
vessels and episodic flow/m9 flow after treatment, time still 
remah& &n impurtant determi~t of the extent of damage 
after acute coroz#y occl@& (31,32); unfortunately, ejrceps 
for the amall numbers of -patients treated in ‘prehospital 
t&ombolys&tri&, typically 55% ‘of patients crur&ntly receive 
thrumb&ysisinth&firsthour. : .- 
y:. ., 
; ,‘~ ,: :-. - 
Table 1. Chara&dcs bf @ieM L ‘@e&pi& Randomized Trk& 
Results of Clinic4 Trials 
Evaluating Mwtafity 
Seveial studies sua;est that vev early tre@ment is ;rlso 
associated with lower mortality. In the Thrombc$sis in Myo- 
cardial infarction II (TIMI: II) angiographic substudy (35), 
patients treated later bad significantly higher mdtiity: 3.2% 
in those treated in the first hour, 52% mortality in the second 
hour and 6.2% mortality in patjents treated in the third and 
fourth hozs. There was also less recurrent &hernia in patients 
treated after the first hour (15% vs; 28%), possibly @gnif$:g 
less viable myocardium in patients who are treated late. 
There have been three controlled prehospical trials evalu- 
ating very early initiation of thrombolytic treatment outside the 
hospital (tit @me) compared with. ib-hdspir@ initikion of ‘, 
.tieitihent. The: characteriiics df p&it&s er&lted- in .th&e ‘. 
studies @d the entr) criteria for these stud& differed’consid- 
erably because of the health care systems ;:I which the trials 
were conducted (Table 1). The largest tr$l,’ the EurOpean 
My&r&al Inf&$& Pioject (EMIP) .(3C;i, enrofied 5=5,000 
patients with suspect&l m@ardial infarction (as determined. 
by a $ysician in tll;e atibultice) atid randomized patie+ jci 
receive e&her prehospital -or hospital-initiatd an~xtreplqse 
&s& 5. Morta!ity .rate related to :timc 
+lay fro~~preh+tal diagnosis to’ hos- 10% 
pital-initiated thiombolysis in the Euro- .g 
pea?-’ Myocardkl Jnfarctioa Project $ 8% 
&ucly. When the d&e&x. exczed;rr Q 
90 niiti, preho.$ial-initiated treatme!rt 
(2x)‘was associated with a 40% !nWer 
= BsQ 
nxxtality rate. {Data frorr, T%c Euro- 
pean Myocardial Infarction Project 4% 
Group [Sal.) 
2% 
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treatment. All patients received aspi.+& ahhough the use of 
heparin was not contrr’led. When the trial ended at half the 
originally intended recruitment, there was an ipignificant 
trend .&ward a reduction in mortality favoring prehospital 
initiation of thrqmbolytic therapy compared with treatment 
initiated in-hospital (9.7% vs. ?l.l%, p ,= 0.08). The greatest 
difference in &come was in patients who had a r90-min delay 
from the time of prehos~ita~ randbtnization until hospital 
initiation of active treatmenr. In this stibset. there was a 40% 
reduction in Mortality in those in whom thef;: was a 90-min or 
longer time savings (F&5). 
In the Grampian study (37,X), iri which general practitio- 
ners randomized patients and then initiated thrumbolytytic 
therapy either outside the hospital at home or after hospital 
arrival, there was a reduction in the incidence in Q wave 
infarction (the primary end point of the trial) in patients 
3ci*a 60-96 
Minutes 
treated veg early at home., In 3 secondary anal),sis. both 
immediate (8% vs. 15.5%) and l-yea; z~~lity rate. wer: 
significantly lower in p:eho+tal-treated patients (t;ig. *;I- 
In the third prehospital tiia! (MITI fSj>, paramedio, n:Jt 
physicians, diagnosed acute r:qocardial infarction and initiated 
thromboiytic therapy. To aid diagnosis, computer-interdicted 
ECGs were obtained in thr: prehospital setting and wmbined 
with a remote consultation with an emergency physician over 
the telephone., Patk;;; i~r the study were al1 evaf*Jated very 
early after symptbin unset (median 35 min), and tiwe to 
treatment for the in-hospital aLated groupwas aIs reiatively 
short (110 min). The prehdspital treatment strategy resulted in 
only a 33-min time saving. There was no dId::ence in mortal- 
ity, ejection fraction or infarct size in the two randomized 
groups. Long-ten follow-l&p at 1 ::~sr in bn:h randomized 
groups has showa no di&xence in the rate of reho@al 
.Fi*“l. @es&s of ;ill cIini&l triak cornpar-- 
ing ‘prehospijai- tid in-hospital thromb&tic 
therapy. The comb&d study results, all 
thbugh inqqence(l niainly by :the European 
Myocardial Infarction Ftiject ‘(EMIP) study, 
show that grehwpiti-initiated thtiombolysis 
is askociated with an 18% relative Tedtiction ti 
mortality rate. Other abbreviations BS in Fi& 
ure 4. (Data from The European Myacardial 
infarction Project Group [Xi].) 
adhksion, rzcurrelit myocardial infarction or mortaiity. Zow- 
ever, a secondaj ana@& &ow&d’ that patients treated ver)v 
early,. within the first 70, min of symptom onset {whether 
o&de or inside the hospital), had signikantly lower mortality 
t&3% vs. 8.7%, p c 0.05) and smaller infarct size (4.9% vs. 
&II%, p K 0.001) than those treated between 70 min and 3 h. 
‘These studies, when combined with other smaller random- 
ized trials tif prehospita&initiated treatment, show that treat- 
-metit outiide the hospital is a?$ciated ki& an 17%, reduction 
in 3Oaay mortality (E’ig. 7). 
Summary and Condusioas 
Initiation of treatment with thmmbolytic therapy within the 
first 40 to ,90 iuin of qmptam dnset can reduce both the size 
and extent of myocardial infarction and mortality; No randorn- 
ied, contraNed p~h~@al&.romholysis trial has bee? large 
enough in, and df itself JO- assess concfusi@y the :effect of . 
pt&ospitaI tr&itmeni~pn mot-t&~. However. m almost every 
study, secuqdary asssments of the &feet of time to ;reatment 
an& outcome have shown that very early treatment results in 
betier but-. In countries where physic&ts are responsible 
for prehoqkal evaIua@ons bf pat@nts wii$ chest Pain and are 
trained t0 a&&ister thrombolytic therxpy,‘prehospitat initi- 
ated treatment is warranted-*nevzi .Li+e *II be a deray in 
treatment of 2 1’ h or *hen p&en@. can receii& treatment’ 
with& hi first hoti,from SymptOm onset; khe United @ate, 
where param& and e~er@~cyt&Juk&ns are res$onsible 
for L& i&id emergenq t+.afgent of s@z$ *tients, prehos$ 
tal Wapy is justified wheri, the ptiders are proved to ,Qe 
capahle of accurately &ientifyittg po&kl ‘k.andid?es, wheti 
remote physician,~n&ation and sup~rvisiut~ are, present tid 
when delays td boapiti tiahent.a= s1.h. ‘. ,. 
Omentry, tie ideal m+hkl of reperfu+n, including~ ty+ 
b3f throti~lfie lhecapy or rnfxhmical meam of reperfusiob by 
e=wpe rtrrtageow tratlslumind mrlIiar)r :armgiopl&* is 
Sti4 ur%der CutlsiderahQ debate. Optimal adjuactive treabmnt 
to thrombolysis, such as heparir: or or?e .of the. new direct 
antithrombins or platelet receptor +king agents, is also yet 
to be defined. These uncertainties in- the treatment regimen 
complicate any standardized prehospltal pr#ocoi rising a 
single treatmerit for all patients widr.acute myocardial infarc- 
tion. Thus, the prehospital use of thrombolysis is currently 
Wiled until these barriers can be overcome. However, it seems 
clear from prehospital studies that attempts to make the 
.dia&osik of acute ,myo@diaI infarction ‘by detecting ST 
segment eievation through the rontine use of prc;hospi?al 
electrocardiography is useful. Such early diagnosis can speed 
in-hospital care. The in-hospital time to treatment needs to be 
s3F min in patients with typical myocardial infarction. This is 
considerably shorter than the 45: to 75-min time delay cur- 
rently attendant in most hospitals. There is also a need to 
develop effective layperson education strategies that reduclt 
the time frdm *ptum onset until initiatioti of rnedicai Care, 
bit &t at’ the c&t of ~Lvet@lizz.ti~~ of eIfiergetit, c&e ~by 
p&ems 9th‘ noncardiac pain. Patietit ,delay- remaiks w 
greatest. source of delay untiI treatnxnt. A meaningfnt rednc- 
tion in &he amount of time (1 to 2 h) to treatment in these two 
areas (gatient- and hoqkl-refaied delays) will be an impof- 
tant means, to improve outcome ;;ftcr acute kyocardial i&r- 
tion. : 
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